Martha M Eibl Selected Research

Staphylococcal enterotoxin F

10/2020	High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm.
1/2009	Analysis of the early response to TSST-1 reveals Vbeta-unrestricted extravasation, compartmentalization of the response, and unresponsiveness but not anergy to TSST-1.
11/2002	Epitope mapping of neutralizing TSST-1 specific antibodies induced by immunization with toxin or toxoids.
1/2002	Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martha M Eibl Research Topics

Disease

8	Septic Shock (Toxic Shock Syndrome) 10/2020 - 01/2002
5	Infections 03/2019 - 11/2008
4	Common Variable Immunodeficiency 01/2022 - 11/2007
3	Cytokine Release Syndrome 10/2020 - 01/2010
2	Primary Immunodeficiency Diseases 01/2022 - 01/2015
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2021 - 11/2002
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021 - 01/2015
2	Bacterial Infections (Bacterial Infection) 01/2015 - 01/2015
1	COVID-19 01/2022
1	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 01/2021
1	Meningoencephalitis 01/2021
1	Persistent Infection 01/2021
1	Shock 10/2020
1	Systemic Vasculitis 01/2020
1	Skin Manifestations 01/2020
1	Evans Syndrome 07/2019
1	Cytopenia 07/2019
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 07/2019
1	Neutropenia 07/2019
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2019
1	Bruton type agammaglobulinemia 03/2019
1	Seizures (Absence Seizure) 10/2017
1	Muscle Hypotonia (Hypotonia) 10/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2017
1	Sudden Infant Death (SID) 01/2015
1	Reinfection 01/2015
1	Virus Diseases (Viral Diseases) 08/2011
1	Sepsis (Septicemia) 01/2010
1	Lymphopenia (Lymphocytopenia) 01/2009
1	Leukopenia 01/2009
1	Type 2 Diabetes Mellitus (MODY) 01/2003
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2003

Drug/Important Bio-Agent (IBA)

6	SuperantigensIBA 01/2022 - 01/2009
6	VaccinesIBA 01/2022 - 01/2002
4	AntigensIBA 01/2022 - 01/2003
4	Staphylococcal enterotoxin FIBA 10/2020 - 01/2002
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2015
3	AntibodiesIBA 01/2022 - 11/2008
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2011
2	Neutralizing AntibodiesIBA 10/2020 - 05/2014
2	SteroidsIBA 01/2020 - 07/2019
2	Intravenous Immunoglobulins (IVIG)FDA Link 07/2019 - 01/2015
2	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 01/2015
2	CytokinesIBA 01/2010 - 01/2003
2	Biological ProductsIBA 01/2010 - 01/2009
1	Messenger RNA (mRNA)IBA 01/2022
1	Immunoglobulin IsotypesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021
1	Rituximab (Mabthera)FDA Link 07/2019
1	Antiviral Agents (Antivirals)IBA 03/2019
1	Retinaldehyde (Retinal)IBA 10/2017
1	Polysaccharides (Glycans)IBA 01/2015
1	Inactivated VaccinesIBA 01/2015
1	Viral AntigensIBA 01/2015
1	Bacterial AntigensIBA 01/2015
1	ABO Blood-Group SystemIBA 01/2015
1	InterferonsIBA 08/2011
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2003
1	Monoclonal AntibodiesIBA 01/2003
1	LipopolysaccharidesIBA 01/2003
1	HLA-DQ Antigens (HLA-DQ)IBA 01/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2003
1	Interleukin-6 (Interleukin 6)IBA 01/2003
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 01/2003
1	Peptides (Polypeptides)IBA 01/2003
1	InterleukinsIBA 01/2003
1	Interleukin-12 (IL 12)IBA 01/2003
1	DNA (Deoxyribonucleic Acid)IBA 11/2002
1	Transcription Factors (Transcription Factor)IBA 11/2002
1	Formaldehyde (Formol)FDA Link 01/2002

Therapy/Procedure

3	Therapeutics 07/2019 - 01/2015
2	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2020
1	Cell Transplantation 07/2019